In the effort to find a treatment for leukemia, Rochester researchers are narrowing their sights on an unlikely target—a daisy-like plant known as feverfew. The Rochester team led by Craig Jordan, director of Translational Research for Hematologic Malignancies at the James P. Wilmot Cancer Center, has been leading the investigation of the therapy for nearly five years. The National Cancer Institute has accelerated the therapy’s development through its rapid access drug program. Clinical trials are under way in England.